Novartis’ Ianalumab granted FDA orphan designation
Ianalumab, for the treatment of primary immune thrombocytopenia, was granted FDA orphan designation, according to a post on the ...
PE Hub3h
Olympus Partners scoops up generic drug maker PAI Pharma
Olympus Partners has acquired PAI Pharma, a US-based manufacturer of generic oral liquids. No financial terms were disclosed. Kurt Orlofski serves as CEO of PAI. PAI Pharma has two large manufacturing ...
Blueprint Medicines selloff to be short-lived, says Oppenheimer
Oppenheimer analyst Matthew Biegler says Blueprint Medicines (BPMC) reported Q4 Ayvakit sales of $146M, in line with consensus but below the ...